Table 5 Odds Ratio for exacerbation in chronic disease as RFE at the OOH Primary Care Service according to frequency in daytime GP contacts during 30 days prior to the index contact
Odds Ratio (95%CI | ||||||||
|---|---|---|---|---|---|---|---|---|
Contacts to GP | N (%) | Crude | Adjusted1 | Adjusted2 | ||||
Heart disease | 152 | (100%) | ||||||
No GP contacts | 37 | (19.4%) | 1 | 1 | 1 | |||
1-2 GP contacts | 90 | (59.4%) | 2.19 | (1.08;4.46) | 2.22 | (1.08;4.59) | 2.21 | (1.47;3.83) |
>2 GP contacts | 25 | (21.2%) | 1.41 | (0.59;3.41) | 1.56 | (1.29;3.71) | 1.54 | (0.51;4.64) |
Lung disease | 83 | (100%) | ||||||
No GP contacts | 28 | (24.6%) | 1 | 1 | 1 | |||
1-2 GP contacts | 41 | (52.9%) | 2.82 | (1.16;6.85) | 2.81 | (1.15;6.91) | 3.20 | (1.42;7.17) |
>2 GP contacts | 14 | (22.4%) | 1.34 | (0.42;4.26) | 1.34 | (0.42;4.25) | 1.49 | (1.08;2.05) |
Diabetes | 381 | (100%) | ||||||
No GP contacts | 109 | (24.0%) | 1 | 1 | 1 | |||
1-2 GP contacts | 197 | (53.1%) | 1.60 | (1.06;2.43) | 1.55 | (1.03;2.36) | 1.51 | (0.99;2.30) |
>2 GP contacts | 75 | (22.9%) | 1.74 | (1.02;2.94) | 1.56 | (0.90;2.70) | 1.54 | (0.89;2.68) |
Psychiatric disease | 131 | (100%) | ||||||
No GP contacts | 57 | (38.7%) | 1 | 1 | 1 | |||
1-2 GP contacts | 49 | (37.3%) | 0.99 | (0.49;1.99) | 0.96 | (0.48;1.97) | 0.98 | (0.48;2.01) |
>2 GP contacts | 25 | (24.0%) | 2.38 | (0.99;5.71) | 2.09 | (0.99;5.14) | 2.15 | (1.00;5.39) |
Cancer | 336 | (100%) | ||||||
No GP contacts | 103 | (23.9%) | 1 | 1 | 1 | |||
1-2 GP contacts | 170 | (52.6%) | 1.65 | (1.07;2.54) | 1.61 | (1.04;2.50) | 1.56 | (1.01;2.43) |
>2 GP contacts | 63 | (22.2%) | 2.39 | (1.37;4.16) | 2.19 | (1.22;3.94) | 2.17 | (1.20;3.91) |
2 + diagnose | 205 | (100%) | ||||||
No GP contacts | 58 | (25.4%) | 1 | 1 | 1 | |||
1-2 GP contacts | 104 | (52.8%) | 1.53 | (0.82;2.83) | 1.51 | (0.82;2.78) | 1.49 | (0.81;2.76) |
>2 GP contacts | 43 | (21.8%) | 1.78 | (0.84;3.75) | 1.63 | (0.75;3.54) | 1.63 | (0.75;3.56) |
Annual follow-up | Crude | Adjusted 1 | Adjusted 2 | |||||
Heart disease | 152 | (100%) | ||||||
No annual follow-up | 120 | (81.2%) | 1 | 1 | 1 | |||
Annual follow-up | 32 | (18.8%) | 0.82 | (0.39;1.73) | 0.84 | (0.40;1.78) | 0.83 | (0.39;1.75) |
Lung disease | 83 | (100%) | ||||||
No annual follow-up | 71 | (80.7%) | 1 | 1 | 1 | |||
Annual follow-up | 12 | (19.3%) | 0.71 | (0.21;2.41) | 0.70 | (0.20;2.48) | 0.68 | (0.19;2.43) |
Diabetes | 381 | (100%) | ||||||
No annual follow-up | 284 | (73.2%) | 1 | 1 | 1 | |||
Annual follow-up | 97 | (26.8%) | 1.07 | (0.71;1.62) | 1.0 | (0.65;1.51) | 0.98 | (0.66;1.55) |
Psychiatric disease | 131 | (100%) | ||||||
No annual follow-up | 115 | (88.0%) | 1 | 1 | 1 | |||
Annual follow-up | 16 | (12.0%) | 0.59 | (0.20;1.74) | 0.48 | (0.17;1.40) | 0.42 | (0.14;1.25) |
Cancer | 336 | (100%) | ||||||
No annual follow-up | 280 | (82.8%) | 1 | 1 | 1 | |||
Annual follow-up | 56 | (17.2%) | 1.00 | (0.58;1.71) | 0.92 | (0.53;1.58) | 0.91 | (0.52;1.58) |
2 + diagnose | 205 | (100%) | ||||||
No annual follow-up | 154 | (78.9%) | 1 | 1 | 1 | |||
Annual follow-up | 51 | (21.1%) | 0.83 | (0.62;1.12) | 0.63 | (0.34;1.17) | 0.61 | (0.33;1.13) |